Q4 2025 MariMed Inc Earnings Call Transcript
Key Points
- MariMed Inc (MRMD) reported full year revenue of $160 million for 2025, marking a 1% increase over 2024 and the sixth consecutive year of positive adjusted EBITDA.
- The company successfully expanded its brand presence, with Betty's Eddies being the number one selling edible in its available markets and its vivacious powdered drink mix ranking fourth in the beverage category.
- MariMed Inc (MRMD) expanded into new markets, including Pennsylvania and New York, and launched Betty's Eddies in Maine through a new licensing agreement.
- The company maintained a strong balance sheet, successfully restructuring convertible stock to enhance financial flexibility and support growth initiatives.
- Retail initiatives, such as the Thrive loyalty program and the launch of a new retail app, contributed to increased transactions and customer engagement, with loyalty program membership growing 31% year over year.
- Despite revenue growth, MariMed Inc (MRMD) faced pricing pressure in mature markets, impacting gross profit margins.
- Retail revenue in Illinois decreased by 26% for the full year compared to 2024, primarily due to price compression in the market.
- Operating income for the full year declined to $8.8 million from $11.4 million in 2024, partly due to lower gross profit in certain markets and negative contributions from Missouri operations prior to exit.
- The company anticipates continued price compression in Illinois and other mature markets in 2026, which could further impact revenue and margins.
- Expansion into Pennsylvania and New York is not expected to significantly contribute to growth in 2026 due to construction and regulatory timelines.
Thank you for standing by. At this time, I would like to welcome everyone to the MariMed fiscal year and fourth quarter 2025 earnings call. (Operator Instructions).
I would now like to turn the conference over to Andrew Pacheco, General Manager for MariMed in Massachusetts. Sir, the floor is yours.
Hello and good morning everyone. I'm Andrew Pacheco, General Manager for Massachusetts at MariMed. I'm honored to kick off today's 2025 fiscal year and fourth quarter earnings call. My team at our New Bedford cultivation and processing facility is responsible for the manufacturing of our great brands that is distributed throughout the state.
I'm privileged to see firsthand the expertise, collaboration, and dedication our employees contribute on a daily basis. They take the company's mission to improve lives every day very seriously. You're going to hear during this call about our performance in Massachusetts in 2025 relative to the rest of the market, and I think it's our team's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
